Kodai Sato

Chiba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.

Clinical Features and Prognostic Significance of Pulmonary Metastases in Metastatic Hormone-sensitive Prostate Cancer.

Journal: Anticancer research

Published: March 17, 2026

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

A Two-Factor Bedside Prognostic Score Integrating Eastern Cooperative Oncology Group (ECOG) Performance Status and Aggressive Metastatic Burden in Metastatic Hormone-Sensitive Prostate Cancer.

Journal: The Prostate

Published: February 03, 2026

Predictive Factors for Operative Time and Blood Loss in Retroperitoneal Laparoscopic Adrenalectomy: A Single-Center Experience.

Predictive Factors for Operative Time and Blood Loss in Retroperitoneal Laparoscopic Adrenalectomy: A Single-Center Experience.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: December 27, 2025

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.

Journal: BJU international

Published: November 13, 2025

Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy.

Prolonged Castration Prior to Docetaxel Reduces Febrile Neutropenia in Patients With Metastatic Hormone-sensitive Prostate Cancer Receiving Triple Therapy.

Journal: Anticancer research

Published: October 28, 2025

Serum Zinc Levels and Skin-related Adverse Events During Systemic Therapy for Renal Cell Carcinoma.

Serum Zinc Levels and Skin-related Adverse Events During Systemic Therapy for Renal Cell Carcinoma.

Journal: In vivo (Athens, Greece)

Published: September 20, 2025

Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.

Impact of Age on Treatment Patterns and Outcomes in Patients With Non-Metastatic Castration-Resistant Prostate Cancer.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: June 02, 2025

Efficacy and safety of a reduced starting dose of cabozantinib (20 mg) plus nivolumab for renal cell carcinoma in real-world practice.

Efficacy and safety of a reduced starting dose of cabozantinib (20 mg) plus nivolumab for renal cell carcinoma in real-world practice.

Journal: Japanese journal of clinical oncology

Published: May 29, 2025

Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Clinical benefits of androgen receptor signaling inhibitors in patients with metastatic hormone-sensitive prostate cancer: real-world data from a multi-center study.

Journal: Japanese journal of clinical oncology

Published: March 26, 2025

Automatic recognition of surgical phase of robot-assisted radical prostatectomy based on artificial intelligence deep-learning model and its application in surgical skill evaluation: a joint study of 18 medical education centers.

Automatic recognition of surgical phase of robot-assisted radical prostatectomy based on artificial intelligence deep-learning model and its application in surgical skill evaluation: a joint study of 18 medical education centers.

Journal: Surgical endoscopy

Published: March 16, 2025

Consecutive real-world treatment experience with a reduced starting dose of lenvatinib (14 mg) plus pembrolizumab for metastatic renal cell carcinoma.

Consecutive real-world treatment experience with a reduced starting dose of lenvatinib (14 mg) plus pembrolizumab for metastatic renal cell carcinoma.

Journal: Japanese journal of clinical oncology

Published: March 13, 2025

The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence.

The Role of Serum Testosterone in the Pathogenesis and Treatment of Prostate Cancer: A Review Based on the Clinical Evidence.

Journal: International journal of urology : official journal of the Japanese Urological Association

Published: January 16, 2025

Showing 1-12 of 26

Last Updated: 09/26/2026